Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,381 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $837.39 | 25 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $523.76 | 9 | $0 (2024) |
| Alkermes, Inc. | $294.52 | 7 | $0 (2024) |
| Axsome Therapeutics, Inc. | $192.64 | 3 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $142.25 | 8 | $0 (2021) |
| UROVANT SCIENCES INC | $101.97 | 1 | $0 (2022) |
| Braeburn Inc. | $95.33 | 1 | $0 (2024) |
| AbbVie Inc. | $85.29 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $62.39 | 2 | $0 (2024) |
| ITI, Inc. | $16.23 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $588.48 | 13 | Otsuka America Pharmaceutical, Inc. ($163.13) |
| 2023 | $1,080 | 27 | Otsuka America Pharmaceutical, Inc. ($424.93) |
| 2022 | $435.51 | 8 | Otsuka America Pharmaceutical, Inc. ($249.33) |
| 2021 | $277.71 | 12 | SUN PHARMACEUTICAL INDUSTRIES INC. ($142.25) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $58.09 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: Neuroscience | ||||||
| 08/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: PSYCHIATRY | ||||||
| 07/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Neuroscience | ||||||
| 05/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $115.90 | General |
| Category: Neuropsychiatry | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $101.19 | General |
| Category: PSYCHIATRY | ||||||
| 04/12/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: CNS | ||||||
| 03/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $63.92 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/20/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $95.33 | General |
| Category: Opioid Use Disorder | ||||||
| 01/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: CNS | ||||||
| 11/14/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $136.18 | General |
| Category: Neuropsychiatry | ||||||
| 10/05/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $70.63 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/15/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: PSYCHIATRY | ||||||
| 08/08/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $104.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $104.56 | General |
| Category: PSYCHIATRY | ||||||
| 07/21/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 142 | 264 | $99,508 | $17,353 |
| 2022 | 6 | 450 | 593 | $116,514 | $33,526 |
| 2021 | 1 | 64 | 64 | $20,736 | $7,967 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 74 | 154 | $51,590 | $8,660 | 16.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 24 | 52 | $17,420 | $2,959 | 17.0% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 18 | 26 | $12,922 | $2,375 | 18.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 15 | 21 | $10,437 | $1,995 | 19.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 11 | 11 | $7,139 | $1,365 | 19.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 76 | 76 | $24,918 | $8,265 | 33.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 97 | 156 | $21,496 | $8,245 | 38.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 67 | 93 | $26,086 | $4,909 | 18.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 70 | 106 | $14,840 | $4,475 | 30.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 48 | 61 | $5,978 | $2,113 | 35.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 22 | 30 | $5,670 | $1,405 | 24.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 11 | 11 | $3,858 | $1,251 | 32.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Facility | 2022 | 27 | 27 | $5,103 | $1,096 | 21.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 13 | 13 | $6,461 | $1,072 | 16.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 19 | 20 | $2,104 | $696.56 | 33.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 53 | 53 | $17,172 | $6,755 | 39.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 11 | 11 | $3,564 | $1,213 | 34.0% |
About Ashley Taylor, PMHNP
Ashley Taylor, PMHNP is a Psychiatric/Mental Health healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2019. The National Provider Identifier (NPI) number assigned to this provider is 1063054955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Taylor, PMHNP has received a total of $2,381 in payments from pharmaceutical and medical device companies, with $588.48 received in 2024. These payments were reported across 60 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,381).
As a Medicare-enrolled provider, Taylor has provided services to 656 Medicare beneficiaries, totaling 921 services with total Medicare billing of $58,847. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Little Rock, AR
- Active Since 10/11/2019
- Last Updated 09/24/2024
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1063054955
Products in Payments
- INGREZZA (Drug) $523.76
- REXULTI (Drug) $375.01
- ABILIFY MAINTENA (Drug) $358.09
- LYBALVI (Drug) $237.65
- Auvelity (Drug) $192.64
- DRIZALMA SPRINKLE (Drug) $106.16
- ABILIFY ASIMTUFII (Drug) $104.29
- GEMTESA (Drug) $101.97
- BRIXADI (Drug) $95.33
- VRAYLAR (Drug) $85.29
- INVEGA SUSTENNA (Drug) $62.39
- KAPSPARGO (Drug) $36.09
- VIVITROL (Drug) $29.72
- ARISTADA (Drug) $27.15
- BRINTELLIX (Drug) $16.23
- CAPLYTA (Drug) $16.23
- SUNOSI (Drug) $13.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Little Rock
Cara Meckfessel, Aprn, APRN
Psychiatric/Mental Health — Payments: $7,199
Michelle Head
Psychiatric/Mental Health — Payments: $5,551
Sara Jones, Phd, Aprn, Pmhnp-Bc, PHD, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,663
Chloe Ward, Aprn, APRN
Psychiatric/Mental Health — Payments: $4,251
Jennifer Rawls, Aprn, APRN
Psychiatric/Mental Health — Payments: $3,031
Kizzie Houston
Psychiatric/Mental Health — Payments: $2,250